BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8624075)

  • 1. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
    Iqbal K; Grundke-Iqbal I
    Ann N Y Acad Sci; 1996 Jan; 777():132-8. PubMed ID: 8624075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
    Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of neurofibrillary degeneration in Alzheimer's disease.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Singh TJ; Grundke-Iqbal I
    Mol Neurobiol; 1994; 9(1-3):119-23. PubMed ID: 7888088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
    J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
    Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological approaches of neurofibrillary degeneration.
    Iqbal K; Grundke-Iqbal I
    Curr Alzheimer Res; 2005 Jul; 2(3):335-41. PubMed ID: 15974899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
    J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
    Iqbal K; Grundke-Iqbal I
    J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.
    Alonso Adel C; Li B; Grundke-Iqbal I; Iqbal K
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8864-9. PubMed ID: 16735465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.
    Iqbal K; Zaidi T; Bancher C; Grundke-Iqbal I
    FEBS Lett; 1994 Jul; 349(1):104-8. PubMed ID: 8045285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology of Alzheimer neurofibrillary degeneration.
    Iqbal K; Alonso A; Gong C; Khatoon S; Kudo T; Singh T; Grundke-Iqbal I
    Acta Neurobiol Exp (Wars); 1993; 53(1):325-35. PubMed ID: 8317268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tau in Alzheimer's disease and related disorders.
    Medeiros R; Baglietto-Vargas D; LaFerla FM
    CNS Neurosci Ther; 2011 Oct; 17(5):514-24. PubMed ID: 20553310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
    Trojanowski JQ; Lee VM
    FASEB J; 1995 Dec; 9(15):1570-6. PubMed ID: 8529836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
    Goedert M; Jakes R; Spillantini MG; Hasegawa M; Smith MJ; Crowther RA
    Nature; 1996 Oct; 383(6600):550-3. PubMed ID: 8849730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.